AAAAAA
Results:
1-14
|
Results: 14
Authors:
Tang, TJ
Batts, KP
de Groen, PC
van Hoek, B
Haagsma, EB
Hop, WCJ
Janssen, HLA
Citation: Tj. Tang et al., The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome, J HEPATOL, 35(3), 2001, pp. 338-343
Authors:
van Nunen, AB
Janssen, HLA
Wolters, LMM
Niesters, HGM
de Man, RA
Schalm, SW
Citation: Ab. Van Nunen et al., Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?, ANTIVIR RES, 52(2), 2001, pp. 139-146
Authors:
Heijtink, RA
Janssen, HLA
Hop, WCJ
Osterhaus, ADME
Schalm, SW
Citation: Ra. Heijtink et al., Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication, J MED VIROL, 63(3), 2001, pp. 217-219
Authors:
Janssen, HLA
Wijnhoud, A
Haagsma, EB
van Uum, SHM
van Nieuwkerk, CMJ
Adang, RP
Chamuleau, RAFM
van Hattum, J
Vleggaar, FP
Hansen, BE
Rosendaal, FR
van Hoek, B
Citation: Hla. Janssen et al., Extrahepatic portal vein thrombosis: aetiology and determinants of survival, GUT, 49(5), 2001, pp. 720-724
Authors:
Lisman, T
Leebeek, FWG
Mosnier, LO
Bouma, BN
Meijers, JCM
Janssen, HLA
Nieuwenhuis, HK
De Groot, PG
Citation: T. Lisman et al., Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is notassociated with increased plasma fibrinolysis, GASTROENTY, 121(1), 2001, pp. 131-139
Authors:
Janssen, HLA
Rosendaal, FR
Citation: Hla. Janssen et Fr. Rosendaal, Acquired and inherited risk factors for Budd-Chiari syndrome and portal vein thrombosis - Response, BLOOD, 97(10), 2001, pp. 3315-3315
Authors:
Heijtink, RA
Janssen, HLA
Hop, WCJ
Osterhaus, ADME
Schalm, SW
Citation: Ra. Heijtink et al., Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy, J VIRAL HEP, 7(5), 2000, pp. 382-386
Authors:
Tang, TJ
Janssen, HLA
van der Vlies, CH
de Man, RA
Metselaar, HJ
Tilanus, HW
de Marie, S
Citation: Tj. Tang et al., Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment?, EUR J GASTR, 12(1), 2000, pp. 123-126
Authors:
van der Vlies, CH
Tang, TJ
Niesters, HGM
Zondervan, PE
Janssen, HLA
de Man, RA
Citation: Ch. Van Der Vlies et al., Acute hepatitis C infection: an indication for alfa interferon therapy?, NETH J MED, 57(1), 2000, pp. 30-33
Authors:
Minnema, MC
Janssen, HLA
Niermeijer, P
de Man, RA
Citation: Mc. Minnema et al., Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability, J HEPATOL, 33(3), 2000, pp. 509-512
Authors:
Janssen, HLA
Citation: Hla. Janssen, Changing perspectives in portal vein thrombosis, SC J GASTR, 35, 2000, pp. 69-73
Authors:
Janssen, HLA
Meinardi, JR
Vleggaar, FP
van Uum, SHM
Haagsma, EB
van der Meer, FJM
van Hattum, J
Chamuleau, RAFM
Adang, RP
Vandenbroucke, JP
van Hoek, B
Rosendaal, FR
Citation: Hla. Janssen et al., Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, BLOOD, 96(7), 2000, pp. 2364-2368
Authors:
Janssen, HLA
Gerken, G
Carreno, V
Marcellin, P
Naoumov, NV
Craxi, A
Ring-Larsen, H
Kitis, G
van Hattum, J
de Vries, RA
Michielsen, PP
ten Kate, FJW
Hop, WCJ
Heijtink, RA
Honkoop, P
Schalm, SW
Citation: Hla. Janssen et al., Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment, HEPATOLOGY, 30(1), 1999, pp. 238-243
Authors:
Janssen, HLA
Van Laar, JM
Van Hoek, B
Den Ottolander, GJ
Van Krieken, JHJM
Breedveld, FC
Citation: Hla. Janssen et al., Severe hepatitis and pure red cell aplasia in adult Still's disease - Goodresponse to immunosuppressive therapy, DIG DIS SCI, 44(8), 1999, pp. 1639-1642
Risultati:
1-14
|